<DOC>
	<DOCNO>NCT01316718</DOCNO>
	<brief_summary>The purpose trial define clinical benefit possible mediator benefit mesalazine Irritable Bowel Syndrome ( IBS ) diarrhoea . The investigator therefore evaluate symptom ( primarily bowel frequency ) marker reflect mast cell activation small bowel tone .</brief_summary>
	<brief_title>Mesalazine Treatment Diarrhoea-predominant Irritable Bowel Syndrome ( IBS-D )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>1 . Male Female patient age 1875 year old able give inform consent . 2 . Patients colonoscopy sigmoidoscopy within last 12 month exclude microscopic colitis . ( If , negative colonoscopy within 5 year symptoms unchanged , sigmoidoscopy mucosal biopsy leave colon would sufficient exclude microscopic colitis ) . 3 . IBSD Patients meet Rome III criterion prior screen phase . 4 . Patients â‰¥ 25 % soft ( score &gt; 4 ) &lt; 25 % hard ( score 1 2 ) stool screen phase , score daily symptom stool diary* . 5 . Patients stool frequency 3 per day 2 day per week screening phase* . 6 . Satisfactory completion daily stool symptom diary screening phase discretion investigator . 7 . Women child bear potential willing able use least one highly effective contraceptive method throughout study . In context study , effective method define result low failure rate ( i.e . le 1 % per year ) use consistently correctly : implant , injectables , combine oral contraceptive , sexual abstinence vasectomise partner . If inclusion criterion 4 and/or 5 is/are meet result consider atypical ( observed medical history patient recall ) patient rescreen 1 occasion . 1 . Women pregnant breast feed 2 . Prior abdominal surgery may cause bowel symptom similar IBS ( note appendectomy cholecystectomy exclusion ) 3 . Patients unable stop antimuscarinics , antispasmodic , high dose tricyclic antidepressant ( i.e . 50 mg/day ) , opiates/antidiarrhoeal drugs* , NSAIDs ( occasional counter use topical formulation allow ) , longterm antibiotic , antiinflammatory drug 5ASA contain drug . 4 . Patients selective serotonin reuptake inhibitor low dose tricyclic antidepressant ( i.e . 50 mg/day ) least 3 month previous unwilling remain stable dose duration trial . 5 . Patients gastrointestinal disease include colitis Crohn 's disease . 6 . Patients follow condition : Renal impairment , severe hepatic impairment salicylate hypersensitivity . 7 . Patients currently participate another trial trial within previous 3 month 8 . Patients opinion investigator consider unsuitable due inability comply instruction 9 . Patients serious concomitant disease e.g . cardiovascular , respiratory , neurological etc . Loperamide allow rescue medication throughout trial , however &gt; 2 dos / week take screen phase eligible , though rescreened 1 occasion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>IBS</keyword>
	<keyword>diarrhoea</keyword>
</DOC>